Insmed Inc. buy Wells Fargo & Company
Start price
29.05.24
/
50%
€46.00
Target price
29.05.25
€71.14
Performance (%)
33.70%
End price
30.05.25
€61.50
Summary
This prediction ended on 30.05.25 with a price of €61.50. The BUY prediction by Wells_Fargo___Compan for Insmed Inc. saw massive gains of 33.70%. Wells_Fargo___Compan has a follow-up prediction for Insmed Inc. where he still thinks Insmed Inc. is a Buy. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Insmed Inc. | -0.714% | -0.714% | 89.116% |
| iShares Core DAX® | -1.933% | 2.239% | 16.921% |
| iShares Nasdaq 100 | -0.972% | 0.226% | 5.003% |
| iShares Nikkei 225® | -2.056% | 5.685% | 19.218% |
| iShares S&P 500 | -1.185% | 0.867% | 2.378% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Insmed Inc. diskutieren
Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at Wells Fargo & Company from $55.00 to $77.00. They now have an "overweight" rating on the stock.
Ratings data for INSM provided by MarketBeat
In the thread Trading Insmed Inc.
Die von Wells_Fargo___Compan gewählte maximale Laufzeit wurde überschritten

